NewsRx

Search our medical news database

Conference Coverage (NCVDG)

Stable Disease, Better Health in Kids on DROVAC Vaccine Therapy

Published in AIDS Weekly, May 26th, 1997

HIV infected children who received an experimental AIDS vaccine have stable immune systems and improved health.

The vaccine, DROVAC, is made from the children's own blood cells. The disrupted cells are rolled up into shell-shaped spiral liposomes known as cochleates, which are administered orally.

Some of the children have been enrolled for two years in the first clinical trial of DROVAC.

"This preliminary therapeutic vaccine trial has demonstrated no adverse clinical or laboratory events, and [has shown] subjective clinical and objective laboratory evidence of stabilization and improvement of HIV disease status over a 20-month...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook